April 23 (Reuters) - Aurinia Pharmaceuticals Inc AUPH.O:
CONCERNED SHAREHOLDERS OF AURINIA PHARMACEUTICALS ANNOUNCE THEIR INTENTION TO WITHHOLD SUPPORT FOR CEO PETER GREENLEAF AT 2025 ANNUAL MEETING
MARKET CAPITAL AND LUCIEN SELCE: BELIEVE AURINIA SHAREHOLDERS WOULD BENEFIT FROM A LEANER, MORE ACCOUNTABLE BOARD
Source text: ID:nBwbr9WfNa
Further company coverage: AUPH.O
((Reuters.Briefs@thomsonreuters.com))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.